Since 1998, MedaPhase has conducted numerous research studies, and has played a major role in the development of some of the most important and innovative dermatology drugs including Protopic, Elidel, Enbrel, Humira, and Stellara.

medaphase-office

Dr. Mark Ling, who previously directed the clinical research program at Emory University School of Medicine in Atlanta, established MedaPhase in 1998. Dr. Ling founded MedaPhase with a mission to bring university-quality clinical dermatology research to the south metro Atlanta area where no such opportunities previously existed. It is Dr. Ling’s belief that clinical research provides a unique opportunity to advance the frontiers of dermatology therapy.

MedaPhase is located with Newnan Dermatology in a state-of-the-art facility, which opened in 2005. It is easily accessible from anywhere in the metro Atlanta area, as well as the surrounding communities of LaGrange, Columbus, and Covington.